Author: ANDREW JACOBS
The U.S. Has Lots of Ventilators — but Too Few Specialists to Mind Them
A burst of production solved the dire shortage that defined the first wave of the coronavirus. But the surplus may not be enough to prevent large numbers of deaths.
Emails Show How Pesticide Industry Influenced U.S. Position in Health Talks
The U.S. insisted that new international guidelines on combating drug resistance omit any mention of fungicides — a demand that the industry made but that ran counter to science.
Drug Giants Create Fund to Bolster Struggling Antibiotic Start-Ups
New medicines are desperately needed to treat a growing number of drug-resistant infections, but many companies developing the drugs are short on cash and investments.
Doctors Heavily Overprescribed Antibiotics Early in the Pandemic
Now they are using lessons from the experience to urge action on the growing problem of drug-resistant infections before it’s too late.
App Shows Promise in Tracking New Coronavirus Cases, Study Finds
The app, which allows people to record their symptoms, was remarkably effective in predicting infections. The most reliable indicators, researchers found, were loss of smell and taste.
Sugary Drink Consumption Plunges in Chile After New Food Law
A study finds that a landmark law requiring warning labels on unhealthy foods made a swift difference in purchases of sodas, bottled water and juices.
Smokers Should Quit at Least 4 Weeks Before Surgery, W.H.O. says
In a new study, the health agency urges hospitals and surgeons to play a bigger role to help the world’s 1 billion smokers kick the habit.
W.H.O. Warns That Pipeline for New Antibiotics Is Running Dry
In two new reports, the global health agency says only government intervention can fix the broken market for new antimicrobial drugs.
Crisis Looms in Antibiotics as Drug Makers Go Bankrupt
First Big Pharma fled the field, and now start-ups are going belly up, threatening to stifle the development of new drugs.